Evidence map›Paper›PMID 24043890›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Ezrin tunes the magnitude of humoral immunity.

Debasis Pore, Neetha Parameswaran, Ken Matsui, Matthew B Stone, Ichiko Saotome, Andrea I McClatchey, Sarah L Veatch, Neetu Gupta

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04627233 (The Clinical Trial of Application of Ezrin Peptide), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04627233 phase1unknown statusnot on this mapstarted 2020, after this paper: background citation

The Clinical Trial of Application of Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection

TypeinterventionalSponsorShahid Beheshti University of Medical SciencesRan2020 to 2021Enrolled20ConditionsCovid19, Treatment, Corona Virus InfectionArmsHuman Ezrin Peptide 1 (HEP1), Placebo
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Inherited human ezrin deficiency impairs adaptive immunity.The Journal of allergy and clinical immunology · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Cutting Edge: Ezrin Regulates Inflammation by Limiting B Cell IL-10 Production.Journal of immunology (Baltimore, Md. : 1950) · 2016
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Debasis PoreDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195;
Neetha Parameswaran
Ken Matsui
Matthew B Stone
Ichiko Saotome
Andrea I McClatchey
Sarah L Veatch
Neetu Gupta
Cleveland Clinic Lerner College of Medicine · USUniversity of Michigan–Ann Arbor · USCenter for Cancer Research · USHarvard University · US

Funding

Regulation of B Cell Function by Membrane-Cytoskeletal RemodelingR01AI081743 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI GUPTA, NEETU · 2009 to 2012
$1.5M
Mechanistic studies of membrane lateral organization in cell plasma membranes.R00GM087810 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI VEATCH, SARAH L · 2010 to 2012
$742k
Regulation of B Cell Function by Membrane-Cytoskeletal RemodelingR56AI081743 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI GUPTA, NEETU · 2014 to 2014
$383k
Mechanistic studies of membrane lateral organization in cell plasma membranes.K99GM087810 · NIGMS · CORNELL UNIVERSITY · PI VEATCH, SARAH L · 2009 to 2010
$127k
NIAID NIH HHS AI081743NIAID NIH HHS R01 AI081743NIAID NIH HHS R56 AI081743NIDDK NIH HHS DK068242NIGMS NIH HHS GM087810NIGMS NIH HHS K99 GM087810NIGMS NIH HHS R00 GM087810
6 · The paper itself

Abstract

Ezrin is a member of the ezrin-radixin-moesin family of membrane-actin cytoskeleton cross-linkers that participate in a variety of cellular processes. In B cells, phosphorylation of ezrin at different sites regulates multiple processes, such as lipid raft coalescence, BCR diffusion, microclustering, and endosomal JNK activation. In this study, we generated mice with conditional deletion of ezrin in the B cell lineage to investigate the physiological significance of ezrin's function in Ag receptor-mediated B cell activation and humoral immunity. B cell development, as well as the proportion and numbers of major B cell subsets in peripheral lymphoid organs, was unaffected by the loss of ezrin. Using superresolution imaging methods, we show that, in the absence of ezrin, BCRs respond to Ag binding by accumulating into larger and more stable signaling microclusters. Loss of ezrin led to delayed BCR capping and accelerated lipid raft coalescence. Although proximal signaling proteins showed stronger activation in the absence of ezrin, components of the distal BCR signaling pathways displayed distinct effects. Ezrin deficiency resulted in increased B cell proliferation and differentiation into Ab-secreting cells ex vivo and stronger T cell-independent and -dependent responses to Ag in vivo. Overall, our data demonstrate that ezrin regulates amplification of BCR signals and tunes the strength of B cell activation and humoral immunity.

Indexed as

Immunity, HumoralActin CytoskeletonAnimalsB-LymphocytesB-Lymphocyte SubsetsCell DifferentiationCell MembraneCell ProliferationCytoskeletal ProteinsEzrinLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutPhosphorylationReceptors, Antigen, B-CellCytoskeletal ProteinsEzrinReceptors, Antigen, B-Cell

Identifiers

PMID24043890
PMCPMC3808844
OpenAlexW2119190655

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.